B
BIOE
vs
S&P 500
S&P 500
Over the past 12 months, BIOE has underperformed S&P 500, delivering a return of -83% compared to the S&P 500's +14% growth.
Stocks Performance
BIOE vs S&P 500
Performance Gap
BIOE vs S&P 500
Performance By Year
BIOE vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Bio Essence Corp
Glance View
Bio Essence Corp. engages in the provision of integrated health supplements and research-intensive products. The company is headquartered in Irvine, California. The company went IPO on 2022-03-30. The firm provides herbal health, diet, and vitamin nutritional supplements through three operational subsidiaries, namely Bio Essence Pharmaceutical, Inc. (BEP) that helps to serves as a health supplement original equipment manufacturer (OEM) service; Bio Essence Herbal Essentials Inc. (BEH), which provides products and service through practitioners' market, and McBE Pharma, Inc. (McBE), which focuses on developing, manufacturing, and sales prescription drugs. Bio Essence Herbal Essentials Inc. targets healthcare practitioners with herbal products in the form of granules, capsules, pills, and tablets. The firm also offers special formulation service to practitioners. Bio Essence provides customers direct connections with integrative healthcare practitioners, such as dietitians, nutraceutical practitioners, and other practitioners.
